The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
The fresh capital will propel Cordance into its first-in-human clinical trial
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
